Advanced non-small-cell lung cancer: how to manage non-oncogene disease

The therapeutic approach to patients affected by advanced non-small-cell lung cancer (NSCLC) is facing rapid and continuous evolution. In recent years, the emergence of new treatment strategies, such as immunotherapy and tyrosine kinase inhibitors, has revolutionized the treatment algorithm and the...

Descripción completa

Detalles Bibliográficos
Autores principales: De Giglio, Andrea, Di Federico, Alessandro, Deiana, Chiara, Ricciuti, Biagio, Brambilla, Marta, Metro, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281971/
https://www.ncbi.nlm.nih.gov/pubmed/35912001
http://dx.doi.org/10.7573/dic.2022-2-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281971/
https://www.ncbi.nlm.nih.gov/pubmed/35912001
http://dx.doi.org/10.7573/dic.2022-2-4

Ejemplares similares